$VRAYQ
ViewRay Inc Stock $vrayq

$vrayq Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000162828022020318 Filed on August 03, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$26.49M	$22.15M	$18.88M
YoY Change	38.13%	47.37%	21.58%
Cost Of Revenue	$22.04M	$21.06M	$18.78M
YoY Change	27.5%	26.08%	23.54%
Gross Profit	$4.454M	$1.091M	$94.00K
YoY Change	135.16%	-165.25%	-70.81%
Gross Profit Margin	16.81%	4.93%	0.5%
Selling, General & Admin	$20.27M	$20.65M	$19.70M
YoY Change	20.55%	22.13%	6.55%
% of Gross Profit	455.1%	1893.03%	20955.32%
Research & Development	$8.100M	$8.412M	$7.870M
YoY Change	-3.23%	6.44%	20.89%
% of Gross Profit	181.86%	771.04%	8372.34%
Depreciation & Amortization	$1.000M	$1.200M	$1.200M
YoY Change	-33.33%	-25.0%	-20.0%
% of Gross Profit	22.45%	109.99%	1276.6%
Operating Expenses	$28.37M	$30.88M	$27.57M
YoY Change	12.65%	24.45%	10.29%
Operating Profit	-$23.92M	-$29.79M	-$27.50M
YoY Change	2.68%	12.48%	11.45%
Interest Expense	$1.509M	$192.0K	$1.064M
YoY Change	42.22%	-81.89%	0.57%
% of Operating Profit
Other Income/Expense, Net	-$1.222M	$2.266M	$2.759M
YoY Change	33.84%	-165.99%	-372.63%
Pretax Income	-$26.11M	-$27.63M	-$25.77M
YoY Change	3.35%	-10.79%	-3.62%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$26.11M	-$27.63M	-$25.77M
YoY Change	3.35%	-10.79%	-3.62%
Net Earnings / Revenue	-98.55%	-124.76%	-136.54%
Basic Earnings Per Share	-$0.14	-$0.15	-$0.14
Diluted Earnings Per Share	-$0.14	-$0.15	-$0.14
COMMON SHARES
Basic Shares Outstanding	181.0M shares	180.6M shares	179.7M shares
Diluted Shares Outstanding	181.0M shares	180.6M shares	179.7M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$142.3M	$157.6M	$180.1M
YoY Change	-5.09%	-5.59%	-1.07%
Cash & Equivalents	$142.3M	$157.6M	$180.1M
Short-Term Investments
Other Short-Term Assets	$10.58M	$6.862M	$10.72M
YoY Change	86.44%	8.92%	41.11%
Inventory	$30.92M	$29.38M	$26.08M
Prepaid Expenses
Receivables	$28.70M	$33.01M	$28.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$221.9M	$233.4M	$252.0M
YoY Change	0.79%	-0.34%	-0.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.02M	$20.23M	$20.36M
YoY Change	-1.54%	-6.99%	-10.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.185M	$11.76M	$11.99M
YoY Change	-8.69%	32.83%	313.48%
Total Long-Term Assets	$38.33M	$43.63M	$46.07M
YoY Change	-4.05%	9.99%	30.5%
TOTAL ASSETS
Total Short-Term Assets	$221.9M	$233.4M	$252.0M
Total Long-Term Assets	$38.33M	$43.63M	$46.07M
Total Assets	$260.2M	$277.0M	$298.1M
YoY Change	0.05%	1.16%	3.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.67M	$16.85M	$9.252M
YoY Change	142.03%	123.96%	21.74%
Accrued Expenses	$18.89M	$15.94M	$18.43M
YoY Change	-2.24%	-12.93%	30.1%
Deferred Revenue	$23.37M	$16.28M	$13.88M
YoY Change	87.46%	47.49%	38.49%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$8.056M
YoY Change
Total Short-Term Liabilities	$83.20M	$76.73M	$79.62M
YoY Change	40.63%	44.8%	61.84%
LONG-TERM LIABILITIES
Long-Term Debt	$58.63M	$58.51M	$49.28M
YoY Change	2.54%	2.46%	-13.54%
Other Long-Term Liabilities	$1.586M	$2.035M	$2.831M
YoY Change	-36.96%	-19.02%	147.03%
Total Long-Term Liabilities	$60.22M	$60.54M	$52.11M
YoY Change	0.87%	1.56%	4447.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$83.20M	$76.73M	$79.62M
Total Long-Term Liabilities	$60.22M	$60.54M	$52.11M
Total Liabilities	$156.0M	$152.2M	$150.6M
YoY Change	9.56%	12.91%	21.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$816.6M	-$790.5M	-$762.9M
YoY Change	15.01%	15.44%
Common Stock	$920.9M	$915.4M	$910.4M
YoY Change	11.25%	11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$104.3M	$124.8M	$147.5M
YoY Change
Total Liabilities & Shareholders Equity	$260.2M	$277.0M	$298.1M
YoY Change	0.05%	1.16%	3.54%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$26.11M	-$27.63M	-$25.77M
YoY Change	3.35%	-10.79%	-3.62%
Depreciation, Depletion And Amortization	$1.000M	$1.200M	$1.200M
YoY Change	-33.33%	-25.0%	-20.0%
Cash From Operating Activities	-$14.38M	-$21.95M	-$32.40M
YoY Change	-10.57%	56.75%	23.16%
INVESTING ACTIVITIES
Capital Expenditures	-$950.0K	-$1.448M	$1.218M
YoY Change	250.55%	535.09%	262.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$950.0K	-$1.448M	-$1.218M
YoY Change	250.55%	535.09%	262.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.000K	929.0K	-$1.548M
YoY Change	-101.33%	-208.65%	-102.98%
NET CHANGE
Cash From Operating Activities	-14.38M	-21.95M	-$32.40M
Cash From Investing Activities	-950.0K	-1.448M	-$1.218M
Cash From Financing Activities	9.000K	929.0K	-$1.548M
Net Change In Cash	-15.32M	-22.47M	-$35.15M
YoY Change	-10.03%	48.94%	-238.94%
FREE CASH FLOW
Cash From Operating Activities	-$14.38M	-$21.95M	-$32.40M
Capital Expenditures	-$950.0K	-$1.448M	$1.218M
Free Cash Flow	-$13.43M	-$20.50M	-$33.62M
YoY Change	-15.05%	48.83%	26.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001597313
	dei	Local Phone Number LocalPhoneNumber	703-3210
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37725
	dei	Entity Registrant Name EntityRegistrantName	ViewRay, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	42-1777485
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Thermo Fisher Way
	dei	Entity Address City Or Town EntityAddressCityOrTown	Oakwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44146
	dei	City Area Code CityAreaCode	440
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01
	dei	Trading Symbol TradingSymbol	VRAY
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	181009565	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157594000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	218348000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33014000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21659000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1676000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3071000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	29380000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	29617000	usd
CY2022Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	6560000	usd
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	4778000	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	1568000	usd
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	3342000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5294000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5803000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	233410000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	283547000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20233000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20242000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4596000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1460000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	41000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7006000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9661000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11758000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6853000	usd
CY2022Q2	us-gaap	Assets Assets	277044000	usd
CY2021Q4	us-gaap	Assets Assets	321807000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	16853000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9199000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15937000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26555000	usd
CY2022Q2	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	24950000	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	20784000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2708000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2561000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3222000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16284000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13920000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	76732000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76241000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6376000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4232000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	58507000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	54031000	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1910000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6795000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6666000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8066000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2035000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2647000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	152226000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	152012000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15030000	usd
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	180997543	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	180997543	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	179206456	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	179206456	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1800000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1782000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	913557000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	905145000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-790539000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-737132000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	124818000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	169795000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277044000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321807000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22149000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41025000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30555000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21058000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16702000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39840000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31905000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1091000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	-1672000	usd
	us-gaap	Gross Profit GrossProfit	1185000	usd
	us-gaap	Gross Profit GrossProfit	-1350000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8412000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7903000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16281000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14413000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7545000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3052000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14429000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5900000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13108000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13858000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25923000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29497000	usd
CY2022Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1816000	usd
CY2021Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1816000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	30881000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	24813000	usd
	us-gaap	Operating Expenses OperatingExpenses	58449000	usd
	us-gaap	Operating Expenses OperatingExpenses	49810000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29790000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-26485000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57264000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-51160000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	83000	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	88000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	192000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	1060000	usd
	us-gaap	Interest Expense InterestExpense	1256000	usd
	us-gaap	Interest Expense InterestExpense	2118000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2266000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3434000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5025000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4446000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27633000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30976000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-53407000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57719000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-27633000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-30976000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-53407000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57719000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	180551041	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	180551041	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	162238348	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	162238348	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	180150867	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	180150867	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	161217083	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161217083	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	169795000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	56000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5032000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1604000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25774000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	147505000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5101000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	490000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	324000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-27633000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	124818000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	130266000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	19000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8494000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1473000	usd
CY2021Q1	vray	Adjustments To Additional Paid In Capital Stock Issued Offering Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOfferingCosts	3991000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	53513000	usd
CY2021Q1	vray	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	2000	usd
CY2021Q1	vray	Adjustments To Additional Paid In Capital Warrant Exercises AdjustmentsToAdditionalPaidInCapitalWarrantExercises	327000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26743000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	164405000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	165000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6455000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1286000	usd
CY2021Q2	vray	Adjustments To Additional Paid In Capital Warrant Exercises AdjustmentsToAdditionalPaidInCapitalWarrantExercises	24000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	264000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-30976000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	139051000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-53407000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57719000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2643000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3171000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10133000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	14949000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	46000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	61000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4885000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4701000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1816000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	477000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	471000	usd
	vray	Product Upgrade Reserve ProductUpgradeReserve	-1600000	usd
	vray	Product Upgrade Reserve ProductUpgradeReserve	1000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11355000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3647000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-256000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4763000	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	1782000	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	1595000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-1774000	usd
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-755000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4630000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5397000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7611000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2508000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-10104000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1374000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8674000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2057000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54333000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40312000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2666000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	568000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2666000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-568000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	57385000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3991000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	914000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	67000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	184000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	322000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	264000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2094000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2759000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-619000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51085000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-57618000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10205000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	219808000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	158180000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162190000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168385000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1695000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1648000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	vray	Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise	0	usd
	vray	Fair Value Of Common Stock Warrants Reclassed From Liability To Additional Paid In Capital Upon Exercise FairValueOfCommonStockWarrantsReclassedFromLiabilityToAdditionalPaidInCapitalUponExercise	351000	usd
	vray	Property And Equipment Transferred From Inventory And Deferred Cost Of Revenue PropertyAndEquipmentTransferredFromInventoryAndDeferredCostOfRevenue	19000	usd
	vray	Property And Equipment Transferred From Inventory And Deferred Cost Of Revenue PropertyAndEquipmentTransferredFromInventoryAndDeferredCostOfRevenue	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	161000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	351000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-53400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54300000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157600000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	56006000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	53600000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35773000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33358000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20233000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20242000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	1200000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	1600000	usd
	us-gaap	Depreciation Depreciation	2600000	usd
	us-gaap	Depreciation Depreciation	3200000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9559000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17080000	usd
CY2022Q2	vray	Accrued Accounts Payable Current AccruedAccountsPayableCurrent	1172000	usd
CY2021Q4	vray	Accrued Accounts Payable Current AccruedAccountsPayableCurrent	3740000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1268000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1094000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	571000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	230000	usd
CY2022Q2	vray	Accrued Product Upgrade Reserve Current AccruedProductUpgradeReserveCurrent	900000	usd
CY2021Q4	vray	Accrued Product Upgrade Reserve Current AccruedProductUpgradeReserveCurrent	2500000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2467000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1911000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15937000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26555000	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	22660000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18152000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16284000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13920000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6376000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4232000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15030000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41025000	usd
CY2022Q2	vray	Accrued Interest Noncurrent AccruedInterestNoncurrent	45000	usd
CY2021Q4	vray	Accrued Interest Noncurrent AccruedInterestNoncurrent	704000	usd
CY2022Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	1008000	usd
CY2021Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	962000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	982000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	981000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2035000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2647000	usd
	vray	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	119420	shares
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	400000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2100000	usd
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3800000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	4900000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4700000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1910000	usd
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9212000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3965000	usd
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5484000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6795000	usd
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4864000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2055000	usd
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3753000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	4885000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4701000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1910000	usd
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9212000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	500000	usd
CY2022Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	600000	usd
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	100000	usd
	us-gaap	Sublease Income SubleaseIncome	100000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	16200000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22149000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30555000	usd
	vray	Long Term Trade Credit Maintenance Services Term LongTermTradeCreditMaintenanceServicesTerm	P1Y
CY2022Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	10100000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	5400000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	11800000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	10600000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5100000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8300000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6900000	usd
CY2022Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	vray	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2036733	shares
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	4900000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4700000	usd
CY2022Q2	vray	Share Based Compensation Arrangement By Share Based Payment Award Number Of Equity Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEquityPlans	2	plan
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	6300000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1501304	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.97
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5100000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6455000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10132000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14949000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7156776	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	220154	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.84
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5203000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	24208	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.76
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6912414	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.96
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1228000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6289250	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1008000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6866646	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.99
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1201000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.20
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1600000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M6D
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3700000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3400000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18314634	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18314634	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18410141	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18410141	shares
CY2022Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1816000	usd
CY2021Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1816000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd

Files In Submission

Name	View Source	Status
0001628280-22-020318-index-headers.html	Edgar Link	pending
0001628280-22-020318-index.html	Edgar Link	pending
0001628280-22-020318.txt	Edgar Link	pending
0001628280-22-020318-xbrl.zip	Edgar Link	pending
exhibit311q22022.htm	Edgar Link	pending
exhibit312q22022.htm	Edgar Link	pending
exhibit321q22022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vray-20220630.htm	Edgar Link	pending
vray-20220630.xsd	Edgar Link	pending
vray-20220630_cal.xml	Edgar Link	unprocessable
vray-20220630_def.xml	Edgar Link	unprocessable
vray-20220630_g1.jpg	Edgar Link	pending
vray-20220630_htm.xml	Edgar Link	completed
vray-20220630_lab.xml	Edgar Link	unprocessable
vray-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRAYQ
ViewRay Inc Stock $vrayq

2022 Q3 Form 10-Q Financial Statement

#000162828022020318 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRAYQ ViewRay Inc Stock $vrayq

2022 Q3 Form 10-Q Financial Statement

#000162828022020318 Filed on August 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRAYQ
ViewRay Inc Stock $vrayq